NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-086-2018-3-EP-04 Zika Viral Antigen Constructs EP DIV 21216477.6 Abandoned
NCI E-257-2009-1-US-25 Use Of IL-15 To Increase Thymic Output US DIV 17/558,365 Abandoned
NCI E-135-2019-0-US-16 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 US National Stage 17/620,942 Pending
NCI E-039-2017-0-US-05 METHODS OF TREATMENT USING PHENYL INDOLE ALLOSTERIC INHIBITORS OF P97 ATPASE US CON 17/556,147 Pending
NCI E-205-2016-0-US-06 NANOPARTICLE TO TARGET CANCER US DIV 17/555,285 11696922 Issued PDF
NEI E-013-2021-0-PCT-02 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE PCT PCT PCT/US2021/064086 Expired
NEI E-070-2019-0-US-07 INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF US National Stage 17/620,248 Pending
NHGRI E-104-2019-0-US-04 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY
MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA 		US National Stage 17/620,331 Pending
NCI E-033-2022-0-US-01 ANTI-MESOTHELIN POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US 63/290,761 Expired
NIAID E-001-2017-1-US-04 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US DIV 17/553,139 11926656 Issued PDF
NCI E-176-2014-0-JP-63 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS JP DIV 2021-203953 Issued
NHGRI E-034-2019-0-HK-17 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA HK CN 62021044683.2 Abandoned
NIAAA E-191-2021-0-US-01 SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS US 63/290,409 Expired
NCI E-135-2019-0-MX-11 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 MX National Stage MX/a/2021/015877 Pending
NCI E-135-2019-0-CA-06 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 CA National Stage 3144070 Pending
NIAID E-024-2021-0-PCT-02 DNA VECTOR AND USES THEREOF FOR DETECTING HIV AND SIV PCT PCT PCT/US2021/063514 Expired
NIAID E-030-2021-0-PCT-02 HUMAN MONOCLONAL ANTIBODIES TARGETING SARS-COV-2 PCT PCT PCT/US2021/063525 Expired
NCI E-135-2019-0-SG-13 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 SG National Stage 11202113949V Pending
NICHD E-184-2021-0-US-01 LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO US 63/289,965 Expired
NIAID E-133-2015-0-US-11 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE US CON 17/551,066 12043660 Issued PDF
NIAID E-007-2015-0-US-36 CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE US CON 17/550,881 11780931 Issued PDF
NCI E-113-2021-0-US-01 BACTERIOPHAGE LAMBDA-VACCINE SYSTEM US 63/289,018 Expired
NCI E-147-2021-0-PCT-02 COMPOSITIONS AND METHODS FOR TREATING CANCER PCT PCT PCT/US2021/062832 Expired
NIAAA E-190-2021-0-US-01 Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds US 63/265,225 Expired
NCI E-175-2016-0-JP-18 ANTI-KRAS-G12D T CELL RECEPTORS JP DIV 2021-199878 Issued
NINDS E-071-2023-0-GB-01 Therapeutics for the Treatment of Neurodegenerative Disorders GB ORD 2117758.9 Pending
NINDS E-198-2021-0-PC-02 Therapeutics for the Treatment of Neurodegenerative Disorders PCT PCT PCT/EP2021/084908 Expired
NIAID E-052-2023-0-PC-01 Combination therapy of N6 and Cabotegravir as a Therapeutic Treatment for HIV PCT PCT PCT/US2021/061697 Expired
NIDA E-183-2021-0-US-01 PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION US 63/286,229 Expired
NIAID E-120-2001-1-AU-06 Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses AU DIV 2021282390 Expired
NCI E-175-2016-0-US-17 ANTI-KRAS-G12D T CELL RECEPTORS US CON 17/541,619 11840561 Issued PDF
NCI E-190-2014-0-US-44 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US CON 17/540,549 12029794 Issued PDF
NCI E-181-2018-2-HK-05 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1(Tdp1) HK EP 62021043492.9 Pending
NCI E-040-2012-0-JP-66 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP DIV 2021-196490 Pending
NCI E-239-2017-0-BR-19 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS BR DIV BR122021024382-4 Pending
NCI E-219-2021-0-US-01 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 63/284,884 Expired
NCI E-021-2015-0-AU-35 Anti-CD70 Chimeric Antigen Receptors AU DIV 2021277627 Issued
NCI E-199-2021-0-US-01 Ribosomal RNA Bait Oligonucleotide To Protect Against C9ORF72 ALS/FTD-associated Poly-GR Pathophysiology US 63/284,485 Expired
NCATS E-005-2022-0-US-01 THREE-DIMENSIONAL RESPIRATORY EPITHELIAL TISSUE CONSTRUCTS WITH PERFUSABLE MICROVASCULATURE ON A HIGH-THROUGHPUT MICROFLUIDICS SCREENING PLATFORM US 63/284,504 Expired
NIAID E-216-2021-0-US-03 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery US 63/284,375 Expired
NCI E-040-2022-0-PC-01 METHODS FOR TREATING BILE DUCT CANCERS WITH TIVOZANIB PCT PCT PCT/US2021/060902 Expired
NCI E-028-2022-0-US-01 METHODS FOR TREATING CANCERS WITH CYTOPLASMIC EXPORTIN 7 (XPO7) EXPRESSION WITH TIVOZANIB US 63/283,406 Abandoned
NEI E-089-2011-0-US-03 CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT US CON 17/534,909 Pending
NCI E-028-2015-1-US-42 ANTI-MUTATED KRAS T CELL RECEPTORS US CON 17/535,318 Pending
NCI E-080-2014-0-US-06 ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US CON 17/532,109 Pending
NCI E-080-2014-0-US-05 ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR
POSITRON EMISSION TOMOGRAPHY 		US DIV 17/532,083 Pending
NIEHS E-241-2020-0-PCT-02 Massively Paralleled Multi-patient Assay For Pathogenic Infection Diagnosis And Host Physiology Surveillance Using Nucleic Acid Sequencing PCT PCT PCT/US21/59996 Expired
NICHD E-009-2021-0-PCT-02 THERAPEUTICS AGAINST PATHOGENIC CORONAVIRUSES PCT PCT PCT/US2021/060122 Expired
NCATS E-234-2020-0-PCT-02 Small Molecule Inhibitors of Sars-Cov-2 Infections PCT PCT PCT/US2021/059910 Expired
NEI E-162-2016-0-HK-33 GENE THERAPY FOR RETINITIS PIGMENTOSA HK EP 42021042687.0 Pending